3.89
Tvardi Therapeutics Inc (TVRD) 最新ニュース
MSN Money - MSN
Street Watch: Can Tvardi Therapeutics Inc stock outperform in 2025 bull marketWeekly Risk Report & Safe Capital Investment Plans - moha.gov.vn
Tvardi Therapeutics (NASDAQ:TVRD) Upgraded at Wall Street Zen - Defense World
Will Q4 Earnings Be a Catalyst for Cubex Tubings LimitedEconomic Data Impact & Free Hedging Tactics for Volatile Markets - earlytimes.in
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? - MSN
Tvardi Therapeutics, Inc. (TVRD) Total Expenses (TTM) - Zacks Investment Research
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
What drives Tvardi Therapeutics Inc. (69C) stock priceEarnings Volatility Patterns & Capitalize On Momentum - earlytimes.in
Tvardi Therapeutics (NASDAQ:TVRD) Stock Rating Lowered by Wall Street Zen - Defense World
What drives Tvardi Therapeutics Inc 69C stock priceLarge Cap Stability Picks & Low Cost Stock Ideas - earlytimes.in
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - TMX Newsfile
Pittsburgh Post-GazetteTvardi Therapeutics, Inc.Common Stock (Nasdaq:TVRD) Stock Quote - FinancialContent
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - FinancialContent
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GuruFocus
Tvardi Therapeutics (NASDAQ:TVRD) Rating Increased to Hold at Wall Street Zen - Defense World
Why retail investors favor Tvardi Therapeutics Inc. stockMarket Activity Report & Free High Return Stock Watch Alerts - Улправда
RSI Check: Will Tvardi Therapeutics Inc. stock recover faster than peersShare Buyback & Stepwise Trade Signal Implementation - Улправда
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GlobeNewswire Inc.
Can Tvardi Therapeutics Inc. stock sustain market leadershipPortfolio Value Summary & Low Risk High Win Rate Picks - Bölüm Sonu Canavarı
Will Tvardi Therapeutics Inc. stock recover faster than peersPortfolio Value Summary & High Conviction Buy Zone Alerts - Улправда
Will Tvardi Therapeutics Inc. stock see insider buyingIPO Watch & Weekly Market Pulse Updates - Улправда
Tvardi Therapeutics grants retention stock options and adopts new severance plan - Investing.com Nigeria
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
Tvardi Therapeutics Earnings Notes - Trefis
What analysts say about Tvardi Therapeutics Inc stockCash Flow Trends & Affordable Portfolio Growth - earlytimes.in
Tvardi Therapeutics Advances STAT3 Inhibitor Clinical Trials - MSN
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - TMX Newsfile
Tvardi Therapeutics (TVRD) Price Target Decreased by 24.64% to 15.15 - MSN
How Low Can Tvardi Therapeutics Stock Really Go? - Trefis
Tvardi Therapeutics (TVRD) Stock Analysis Report | Financials & Insights - Benzinga
Will Tvardi Therapeutics Inc. (69C) stock outperform value peersJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Can Tvardi Therapeutics Inc. stock sustain institutional interestTrade Exit Summary & Detailed Earnings Play Alerts - Newser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates - GuruFocus
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - Barchart.com
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Tvardi Therapeutics - Menafn.com
Is Tvardi Therapeutics Inc. (69C) stock trading at attractive multiplesChart Signals & Fast Exit and Entry Trade Guides - Newser
Why Tvardi Therapeutics Inc. (69C) stock could outperform next yearWeekly Profit Analysis & Technical Pattern Recognition Alerts - Newser
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... - Herald and News
With Tvardi Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Will Tvardi Therapeutics Inc. (69C) stock see insider accumulationJuly 2025 Big Picture & Low Drawdown Trading Techniques - Newser
How big funds are accumulating Tvardi Therapeutics Inc. (69C) stockJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Tvardi Therapeutics - The National Law Review
大文字化:
|
ボリューム (24 時間):